Background Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in
hospitalized patients. While numerous randomized controlled trials (RCTs) have shown that …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Objectives: Validate a retrospective venous thromboembolism (VTE) risk scoring method,
which was developed at the University of Michigan Health System and based on the Caprini …

Background After hip replacement surgery, prophylaxis following discharge from hospital is
recommended to reduce the risk of venous thromboembolism. Our aim was to assess the …

Background Acutely ill, hospitalized medical patients are at risk of VTE. Despite guidelines
for VTE prevention, prophylaxis use in these patients is still poor, possibly because of fear of …

Background: Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin
inhibitor, that do not require monitoring or dose adjustment offer potential for prophylaxis …

Background Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but
international normalized ratio (INR) monitoring is required. Target INRs are frequently not …

Introduction Increased risk of venous thromboembolism following major orthopedic surgery
(MOS) is well described. The American Academy of Chest Physician (ACCP) has generated …

Venous thromboembolism (VTE) is a major US health problem. However, the total number of
US inpatients who are at risk for VTE is unknown. Our objective was to estimate the number …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …